Full-Time

Scientist 3

Large Molecule, Liquid Chromatography/Mass Spectrometry

Posted on 1/5/2026

BioAgilytix

BioAgilytix

501-1,000 employees

Global bioanalytical testing for drug development

No salary listed

Durham, NC, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • Bachelor’s degree in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than 12 years’ experience in a scientific laboratory environment; or Master’s degree in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than ten (10) years’ experience in a scientific laboratory environment; or PhD in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than eight (8) years’ experience in a scientific laboratory environment
  • Knowledge of regulatory guidance and industry best practices for LC/MS, and other large molecule assays
Responsibilities
  • Serve as Bioanalytical Project Manager (BPM)/Principal Investigator (PI), overseeing all aspects of bioanalytical studies including project scope definition, proposal preparation, timelines, scheduling, budget, and revenue management.
  • Act as primary client contact, presenting data, ensuring clear communication, and aligning project deliverables with client timelines and expectations.
  • Lead assay development, validation, and sample analysis of biologics, proteins, peptides, ADCs, and/or biomarkers using chromatographic and mass spectrometric (LC/MS) techniques in support of preclinical, clinical, and product release studies.
  • Design, plan, and execute experiments independently; troubleshoot assays; analyze and interpret data; prepare summary tables, plans, reports, and SOPs.
  • Ensure GLP compliance throughout assay development, validation, and sample analysis activities, including prompt identification and notification of deviations and preparation of associated documentation.
  • Set up and manage studies in LIMS; maintain accurate laboratory records, worksheets, and raw data with peer review.
  • Train, mentor, and direct junior scientists and analysts, including preparing and reviewing scientific training materials.
  • Provide scientific leadership by planning experimental designs for junior staff and driving bioanalytical projects to successful completion.
Desired Qualifications
  • Bachelor’s degree in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than 12 years’ experience in a scientific laboratory environment; or Master’s degree in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than ten (10) years’ experience in a scientific laboratory environment; or PhD in molecular biology, biochemistry, immunology, biotechnology, or related field with not less than eight (8) years’ experience in a scientific laboratory environment
  • Knowledge of regulatory guidance and industry best practices for LC/MS, and other large molecule assays
  • Demonstrated expertise in developing chromatographic and mass spectrometric assays including LC/MS and LC/MS/MS for bioanalytical studies by extracting analytes of interest from complex biological matrices using protein precipitation, liquid-liquid, solid phase, immunoprecipitation or other extraction technique
  • Advanced capabilities in data analysis, data visualization statistical analysis
  • Microsoft Word, Excel, Sciex OS/Analyst, MassLynx, XCalibur, Chromeleon, Watson LIMS, JMP, Graphpad Prism
  • GDP, GLP, GCLP, GCP
  • Experience with development, validation and execution of chromatographic and mass spectrometric assays (LC/MS), and/or ability to perform most tasks associated with custom research planning and bench work
  • Must work effectively within team to meet objectives under time constraints
  • A knack for designing efficient and impactful experiments
  • Experience working in a regulated environment, with a thorough understating of GDP, GLP, GCLP, GCP
  • Independence, enthusiasm, openness, and adaptability
  • Demonstrated effective communication skills
  • The ability to inspire others to do their best work and drive results
  • Excellent customer service skills (internal and external)

BioAgilytix is a global bioanalytical laboratory that provides testing services for pharmaceutical, biotechnology, and agricultural biotech companies, with a notable presence in Hamburg, Europe. It specializes in large-molecule studies and runs assays such as pharmacokinetics, pharmacodynamics, cell-based tests, and immunogenicity to measure how drugs behave in the body and assess safety and efficacy. The company offers customizable, service-based testing that supports drug development from research through regulatory approval, including COVID-19 testing packages. Its differentiators are its global reach, deep expertise in large-molecule workflows, and a flexible model that partners with clients on a project basis. Its goal is to deliver precise, validated bioanalytical data that helps clients develop and bring new therapies to market.

Company Size

501-1,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$30.1M

Headquarters

Durham, North Carolina

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Gene therapy market expansion as anti-AAV assay addresses rare disease diagnostics.
  • European market growth through Hamburg lab qPCR expansion and leadership hires.
  • Strategic partnerships with BBI Solutions and A3P Biomedical diversify revenue streams.

What critics are saying

  • Cancelled $61.5M Durham expansion forfeits 878 jobs, damaging talent acquisition capacity.
  • Charles River and Labcorp undercut pricing via integrated CRO scale advantages.
  • Eurofins AI-optimized assays deliver 40% faster turnaround, threatening biotech client retention.

What makes BioAgilytix unique

  • FDA Breakthrough Device Designation for anti-AAV antibody assay supporting gene therapy.
  • Global laboratory network across US, Australia, Germany enabling early-phase to market authorization.
  • Specialized expertise in large molecule bioanalysis, immunogenicity, and cell-based assays.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Company Match

Parental Leave

Employee Referral Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

18%
The Associated Press
Feb 10th, 2026
BioAgilytix receives FDA breakthrough device designation for anti-AAV antibody assay supporting gene therapy

BioAgilytix Labs has received FDA Breakthrough Device Designation for its anti-AAV antibody assay supporting Lexeo Therapeutics' gene therapy programme for Friedreich ataxia cardiomyopathy, a rare progressive disorder affecting approximately 15,000 people worldwide. The plate-based MSD anti-adeno-associated virus serotype rh.10 total antibody assay enables precise patient selection and monitoring for gene therapy programmes. The FDA's Breakthrough Device Designation expedites development and review of novel medical devices treating life-threatening or irreversibly debilitating conditions. BioAgilytix is among a limited number of contract research organisations to receive breakthrough designation for a diagnostic assay supporting an investigational device exemption. The Durham, North Carolina-based company operates laboratories across the US, Australia and Germany, providing bioanalytical testing services for pharmaceutical and biotechnology organisations.

Rapid Test Methods Ltd
Jun 18th, 2024
BBI and BioAgilytix Partner to Streamline and Simplify Bioanalytical Testing

BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership agreement with BioAgilytix, a leading global bioanalytical laboratory.

The Business Journals
Mar 26th, 2024
Durham firm cancels deal that promised 878 jobs

BioAgilytix in 2020 picked the Triangle over competing sites in Massachusetts for a $61.5 million expansion that was expected to add 878 local jobs.

360Dx
Sep 13th, 2023
A3P Biomedical, BioAgilytix Partner to Bring Prostate Cancer Test to US

NEW YORK - Swedish diagnostics firm A3P Biomedical announced on Wednesday that it has partnered with BioAgilytix to bring A3P's prostate cancer test to the US as a laboratory-developed test.

A3P Biomedical
Sep 13th, 2023
A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA

Recognizing the critical need for improved prostate cancer diagnostics, A3P Biomedical and BioAgilytix have joined forces to introduce Stockholm3 as a novel LDT in the US market.

INACTIVE